Revenue (Annual) Chart

View Revenue (Annual) for DGWPF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Annual) Chart
Start Trial

Historical Revenue (Annual) Data

View and export this data back to 1983. Start Trial.
Date Value
December 31, 2025 3.930B
December 31, 2024 3.646B
December 31, 2023 3.647B
December 31, 2022 3.200B
December 31, 2021 3.934B
December 31, 2020 3.883B
December 31, 2019 3.112B
December 31, 2018 3.061B
December 31, 2017 2.901B
December 31, 2016 2.792B
December 31, 2015 2.893B
December 31, 2014 3.229B
December 31, 2013 3.152B
December 31, 2012 3.049B
December 31, 2011 3.137B
December 31, 2010 2.881B
December 31, 2009 2.657B
December 31, 2008 2.816B
December 31, 2007 2.491B
December 31, 2006 2.261B
December 31, 2005 2.026B
December 31, 2004 1.889B
Date Value
December 31, 2003 1.597B
December 31, 2002 1.257B
December 31, 2001 1.125B
December 31, 2000 1.047B
December 31, 1999 1.086B
December 31, 1998 1.094B
December 31, 1997 1.013B
December 31, 1996 938.81M
December 31, 1995 861.63M
December 31, 1994 830.69M
December 31, 1993 817.65M
December 31, 1992 789.84M
December 31, 1991 763.24M
December 31, 1990 663.63M
December 31, 1989 590.65M
December 31, 1988 579.15M
December 31, 1987 543.61M
December 31, 1986 496.98M
December 31, 1985 495.38M
December 31, 1984 456.36M
December 31, 1983 403.51M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Annual) Range, Past 5 Years

View Revenue (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Annual) Benchmarks

View Revenue (Annual) Benchmarks
Start Trial
Ottobock SE & Co. KGaA 1.896B
Abbott Laboratories 44.33B
AngioDynamics, Inc. 320.17M
Alphatec Holdings, Inc. 764.16M
AtriCure, Inc. 534.53M